Trial · NCT07888335
Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological Lesions
NCT07888335, Phase 4, Not yet recruiting, Ruijin Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological Lesions. Trials, record NCT07888335. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888335
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological Lesions
- NCT number
- NCT07888335
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 20 participants, estimated
- Lead sponsor
- Ruijin Hospital
- Conditions
- Primary IgA Nephropathy
- Interventions
- Obinutuzumab Beta
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent change in 24-hour urinary protein from baseline at Week 24 | Baseline, Week 24 | |
| Secondary | Change in 24-hour urinary protein/UPCR from baseline at Weeks 12, 36, and 52 | Baseline, Weeks 12, 36, 52 | |
| Secondary | Change in eGFR from baseline at Weeks 12, 24, 36, and 52 | Baseline, Weeks 12, 24, 36, 52 | |
| Secondary | Proportion of patients with 24-hour urinary protein <0.5 g/d at Weeks 12, 24, 36, and 52 | Baseline, Weeks 12, 24, 36, 52 | |
| Secondary | Change in Gd-IgA1 levels from baseline at Weeks 12, 24, 36, and 52 | Baseline, Weeks 12, 24, 36, 52 | |
| Secondary | Proportion of patients with disease relapse up to Week 52 | Up to Week 52 | |
| Other | Change in renal biopsy pathological indicators at Week 52 | Baseline, Week 52 | |
| Other | Incidence and type of adverse events (AEs) and serious adverse events (SAEs) | From first dose to Week 52 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888335
GET https://conductscience.org/api/trials/v1/NCT07888335/registered